This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University System of Maryland. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Rebecca Whipple-Bettes: Innovator in Cancer Research
Introduction
Rebecca Whipple-Bettes is a notable inventor based in Columbia, MD (US). She has made significant contributions to the field of cancer research, particularly in understanding and inhibiting microtubule protrusions in cancer cells. Her innovative work aims to improve therapeutic strategies for cancer treatment.
Latest Patents
Rebecca holds a patent titled "Inhibition of microtubule protrusion in cancer cells." This invention focuses on the inhibition of microtubule protrusions in cancer cells, including detached cancer cells. The patent describes how inhibiting these protrusions can interfere with the attachment of cancer cells to vessel walls. Furthermore, it explores methods to force cancer cells into capillaries, leading to their destruction through shearing. This innovative approach has the potential to enhance cancer treatment methodologies.
Career Highlights
Rebecca Whipple-Bettes is affiliated with the University System of Maryland, where she conducts her research. Her work has garnered attention for its potential impact on cancer therapies. She is dedicated to advancing the understanding of cancer cell behavior and developing new strategies to combat this disease.
Collaborations
Rebecca collaborates with Stuart Martin, contributing to the advancement of cancer research through their combined expertise. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Rebecca Whipple-Bettes is a pioneering inventor whose work in cancer research is making strides toward more effective treatments. Her patent on inhibiting microtubule protrusions in cancer cells showcases her commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
